Photosynthetic Plant-Derived Nanovesicles Precisely Amplify Photodynamic Effect by Light-Activated Oxygen Generation for Enhanced Cancer Photoimmunotherapy
ACS Nano · 2025
DOI: 10.1021/acsnano.5c13350 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Jiangang Mei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Researc…. Hauptthemen laut MEDLINE: Photochemotherapy, Nanoparticles, Immunotherapy, Oxygen. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Photodynamic immunotherapy has emerged as a promising cancer therapeutic strategy, yet its efficacy is crucially hindered by the hypoxic and immunosuppressive tumor microenvironment (TME). Herein, we present a bioinspired nanoplatform that leverages the natural photosynthetic capabilities of spinach-derived nanovesicles (SDNV) for light-excited oxygen evolution to address this critical challenge. SDNV is engineered to encapsulate aggregation-induced emission luminogens (AIEgen), forming AIE@SDNV nanoparticles with excellent biocompatibility and transmembrane permeability. Upon irradiation, SDNV generates substantial oxygen as a substance for AIEgen to produce reactive oxygen species, thus improving the photodynamic efficacy by triggering severe cellular lipid peroxidation and calcium ion imbalance. This leads to potent tumor cell destruction and immunogenic cell death. Subsequently, significant release of damage-associated molecular patterns from tumor cells enhances systemic antitumor immunity via the cGAS-STING signaling pathway and activates immune responses within the TME. Moreover, SDNV enables precise AIEgen delivery and prolonged tumor retention. Simultaneously, AIE@SDNV-mediated photoimmunotherapy effectively suppresses both primary and distant tumors in a bilateral tumor model. This study provides a promising strategy for efficiently delivering a therapeutic agent, improving hypoxia-restricted photodynamic therapy, and reversing the immunosuppressive TME, thereby achieving potentiated antitumor efficacy and highlighting the potential of plant-derived nanovesicles in advancing cancer nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Lab…
- Guangdong Provincial Clinical Research Center for Laboratory Medicine, Guangzhou 510515, P. R. China.
- State Key Laboratory of Multi-organ Injury Prevention and Treatment, Nanfang Hospital, Southern Medical University, Guangzhou 510515, P. R. China.
ORCID-Profile: Weilun Pan, Bo Li, Lei Zheng
Förderung
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Mei, J., Pan, W., Li, B., Zhong, M., Shi, X., Cheng, Y., Wu, B., Xiu, Q., Xue, Y., Situ, B., & Zheng, L. (2025). Photosynthetic Plant-Derived Nanovesicles Precisely Amplify Photodynamic Effect by Light-Activated Oxygen Generation for Enhanced Cancer Photoimmunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.5c13350
Vancouver
Mei J, Pan W, Li B, Zhong M, Shi X, Cheng Y, et al. Photosynthetic Plant-Derived Nanovesicles Precisely Amplify Photodynamic Effect by Light-Activated Oxygen Generation for Enhanced Cancer Photoimmunotherapy. ACS Nano. 2025. doi:10.1021/acsnano.5c13350
BibTeX
@article{Mei2025,
author = {Mei, Jiangang and Pan, Weilun and Li, Bo and Zhong, Mingzhen and Shi, Xiudong and Cheng, Yanfang and Wu, Bodeng and Xiu, Qi and Xue, Yicong and Situ, Bo and Zheng, Lei},
title = {Photosynthetic Plant-Derived Nanovesicles Precisely Amplify Photodynamic Effect by Light-Activated Oxygen Generation for Enhanced Cancer Photoimmunotherapy},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c13350}
}
EUVIMED